Advances in clinical chemistry. Volume 71 /
| Άλλοι συγγραφείς: | |
|---|---|
| Μορφή: | Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Amsterdam :
Academic Press,
2015.
|
| Σειρά: | Advances in Clinical Chemistry ;
v. 71. |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Title page; Table of Contents; Copyright; Contributors; Preface; Chapter One: Biomarkers in Breast Cancer: Where Are We and Where Are We Going?; Abstract; 1 Use of Biomarkers in the Identification of Women at Increased Risk of Developing Breast Cancer (Risk Assessment); 2 Use of Biomarkers in Determining Prognosis; 3 Use of Biomarkers in Guiding Treatment; 4 Use of Biomarkers in the Postoperative Follow-Up of Asymptomatic Patients Following Curative Surgery; 5 Use of Biomarkers in Monitoring Therapy in Patients with Metastasis; 6 Emerging Biomarkers for Breast Cancer; 7 Conclusion
- AcknowledgmentsChapter Two: Polycystic Ovary Syndrome-Epigenetic Mechanisms and Aberrant MicroRNA; Abstract; 1 Introduction; 2 The Epigenetic Landscape; 3 miRNA; 4 Conclusions; Acknowledgments; Chapter Three: EN2 in Prostate Cancer; Abstract; 1 Introduction; 2 Risk Factors and Conventional Biomarkers of Prostate Cancer; 3 Biomarkers with Clinical Application in Urine; 4 Antitumor Antibodies as Biomarkers; 5 The Homeobox Gene Superfamily; 6 The Biology of En; 7 En in Cancer; 8 En as a Potential Biomarker in Cancer; 9 EN2 in Prostate Cancer
- 10 EN2 as a Diagnostic Marker and Marker of Significant Disease11 EN2 in Men at High Risk of Prostate Cancer; 12 Future Perspectives; 13 Conclusion; Chapter Four: Cytochrome P450 in Cancer Susceptibility and Treatment; Abstract; 1 Introduction; 2 Classification, Nomenclature, and Structure of Cytochromes P450; 3 Drug Metabolism; 4 Genetic Variations in CYP450 Isoforms; 5 CYP450 in Cancer Susceptibility; 6 CYP450 in Anticancer Therapy; 7 Conclusion; Acknowledgments; Chapter Five: The Importance of Accurately Assessing Renal Function in the Neonate and Infant; Abstract; 1 Introduction
- 2 The Normal Development of Renal Function Before Birth3 Adaptation of Hemodynamics and Renal Function After Birth; 4 Can Nephrogenesis Continue After Preterm Birth?; 5 Measuring Renal Function; 6 Neonatal Kidney Size and Renal Function in Preterm Infants; 7 Should We Move to CysC-Derived eGFR When Dosing Aminoglycosides and Other Renally Excreted in Neonates?; Acknowledgments; Chapter Six: Systematic Assessment of the Hemolysis Index: Pros and Cons; Abstract; 1 Introduction; 2 The Hemolysis Index; 3 Pros and Cons; 4 Conclusions
- Chapter Seven: Peroxisome Proliferator-Activated Receptor α in Lipid Metabolism and AtherosclerosisAbstract; 1 Introduction; 2 PPARα Expression; 3 PPARα Structure and Activation; 4 PPARα and Lipid Metabolism; 5 PPARα and Lipoprotein Metabolism; 6 The Roles of PPARα in Atherosclerosis; 7 Therapeutic Potential of PPARα Agonists in Atherosclerosis and Dyslipidemia; 8 Conclusions and Perspectives; Acknowledgments; Index
